LEMAITRE VASCULAR, INC. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- LEMAITRE VASCULAR, INC. payments for repurchase of common stock for the quarter ending 2026-06-30 was $17.00K, a 325.00% increase year-over-year.
- LEMAITRE VASCULAR, INC. payments for repurchase of common stock for the quarter ending 2026-03-31 was $460.00K, a 23.46% decline year-over-year.
- LEMAITRE VASCULAR, INC. payments for repurchase of common stock for the quarter ending 2025-12-31 was $1.22M, a 10.13% decline year-over-year.
- LEMAITRE VASCULAR, INC. payments for repurchase of common stock for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- LEMAITRE VASCULAR, INC. payments for repurchase of common stock for fiscal 2025 was $1.82M, a 5.93% increase from fiscal 2024.
- LEMAITRE VASCULAR, INC. payments for repurchase of common stock for fiscal 2024 was $1.72M, a 101.52% increase from fiscal 2023.
- LEMAITRE VASCULAR, INC. payments for repurchase of common stock for fiscal 2023 was $853.00K, a 32.87% increase from fiscal 2022.
- LEMAITRE VASCULAR, INC. payments for repurchase of common stock for fiscal 2022 was $642.00K, a 19.95% decline from fiscal 2021.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2026-06-30 | $17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.69M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $460.00K 10-Q · filed 2026-05-06 | $1.68M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.82M 10-K · filed 2026-02-26 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $1.96M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.96M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $601.00K 10-Q · filed 2026-05-06 | $1.96M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.72M 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $1.03M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $1.04M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $358.00K 10-Q · filed 2025-05-08 | $1.04M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $667.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $853.00K 10-K · filed 2026-02-26 |
| 2023-09-30 | $5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $676.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $674.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $172.00K 10-Q · filed 2024-05-10 | $669.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $490.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $642.00K 10-K · filed 2025-02-28 |
| 2022-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $580.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $863.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $145.00K 10-Q · filed 2023-05-09 | $859.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $428.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $802.00K 10-K · filed 2024-02-29 |
| 2021-09-30 | $286.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $653.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $601.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $88.00K 10-Q · filed 2022-05-10 | $601.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $279.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $570.00K 10-K · filed 2023-03-01 |
| 2020-09-30 | $234.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $528.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $717.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $57.00K 10-Q · filed 2021-05-10 | |
| 2019-12-31 | $237.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $683.00K 10-K · filed 2022-02-28 |
| 2019-09-30 | $423.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | |
| 2018-12-31 | $63.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $741.00K 10-K · filed 2021-03-12 |
| 2018-09-30 | $673.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $778.00K 10-K · filed 2020-03-12 |
| 2016-12-31 | $128.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-11 | $311.00K 10-K · filed 2019-03-11 |
| 2016-09-30 | $181.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $266.00K 10-K · filed 2018-03-09 |
| 2015-09-30 | $260.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $266.00K derived: sum of 4 quarters · filed 2017-03-09 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $210.00K derived: sum of 4 quarters · filed 2017-03-09 |
| 2015-03-31 | $6.00K 10-Q · filed 2016-05-06 | $216.00K derived: sum of 4 quarters · filed 2017-03-09 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $211.00K 10-K · filed 2017-03-09 |
| 2014-09-30 | $204.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $250.00K derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-06-30 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $277.00K derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-03-31 | $1.00K 10-Q · filed 2015-05-07 | $284.00K derived: sum of 4 quarters · filed 2016-03-10 |
| 2013-12-31 | $39.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $373.00K 10-K · filed 2016-03-10 |
| 2013-09-30 | $231.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $370.00K derived: sum of 4 quarters · filed 2015-03-18 |
| 2013-06-30 | $13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $1.01M derived: sum of 4 quarters · filed 2015-03-18 |
| 2013-03-31 | $90.00K 10-Q · filed 2014-05-08 | $1.51M derived: sum of 4 quarters · filed 2015-03-18 |
| 2012-12-31 | $36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-18 | $2.02M 10-K · filed 2015-03-18 |
| 2012-09-30 | $875.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $2.74M derived: sum of 4 quarters · filed 2014-03-21 |
| 2012-06-30 | $508.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $2.80M derived: sum of 4 quarters · filed 2014-03-21 |
| 2012-03-31 | $602.00K 10-Q · filed 2013-05-08 | $2.44M derived: sum of 4 quarters · filed 2014-03-21 |
| 2011-12-31 | $754.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21 | $2.21M 10-K · filed 2014-03-21 |
| 2011-09-30 | $937.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $2.66M derived: sum of 4 quarters · filed 2013-03-27 |
| 2011-06-30 | $146.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-10 | $2.32M derived: sum of 4 quarters · filed 2013-03-27 |
| 2011-03-31 | $376.00K 10-Q · filed 2012-05-03 | |
| 2010-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-27 | $2.52M 10-K · filed 2013-03-27 |
| 2010-09-30 | $595.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | |
| 2009-12-31 | $686.00K 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |